Gregory Scott Duncan, Chief Executive Officer at Virios Therapeutics, Inc. (VIRI), bought 31,350 shares at $6.17 ($193K) on 2021-04-05, disclosed to the SEC on 2021-04-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.17 | 15,675 | $97K | 50.0% |
| 2 | $6.17 | 15,675 | $97K | 50.0% |
| Total | $6.17 avg | 31,350 | $193K | 100% |
| Filing → |
| VIRI | BUY | 2021-12-22 | $28K | — | Filing → |
| VIRI | BUY | 2021-04-07 | $2K | — | Filing → |